Category: Research

On 6 March, we’re hosting a unique opportunity to get your research questions answered as our Scientific Advisory Board comes together from across the globe

Results of two phase 2 clinical trials testing cabozantinib suggest that anti-angiogenic therapy could be used to treat glioblastomas

Researchers at Massachusetts General Hospital prepare to launch a phase 1 clinical trial to test the combination therapy of hydroxyurea and temozolomide (TMZ)

Our Research Engagement Manager Becky Birch, outlines developments highlighted by Tessa Jowell’s debate

In her interview on the Today programme, Tessa Jowell talked about adaptive clinical trials. Find out more

A study involving multiple institutions in the United States reported that conventional cancer therapy initiates a series of events that encourage living cancer cells to grow and develop new tumours

Researchers have discovered that the circadian rhythm, also known as a person’s ‘internal clock’, could hold the answers to develop new therapies for glioblastoma

Scotland-based charity, Worldwide Cancer Research, has formed a unique partnership with us to fund two outstanding scientists’ work on brain cancer

Research funded by The Brain Tumour Charity has proved for the first time that a naturally-occurring virus can cross the blood-brain barrier in humans and attack tumour cells in the brain

Patients with glioblastoma are wearing a cap that delivers electronic fields to treat their brain tumours

Our Head of Research, Phil Hexley, outlines what happened at SNO: the 22nd Annual Meeting and Education Day of the Society for Neuro-Oncology

Researchers at UC San Francisco develop a vaccine to treat diffuse midline glioma by using the patient’s immune system to attack the tumour cells

Our Head of Research, Phil Hexley, outlines what happened at SNO: the 22nd Annual Meeting and Education Day of the Society for Neuro-Oncology

PAC-1, an anti-cancer drug is approved for phase 1(b) clinical trials in humans by the US Food and Drug Administration

Researchers in collaboration with ZIOPHARM Oncology, a biopharmaceutical company announce positive updates on a Phase 1 clinical trials testing a new therapy

Ally is an academic psychiatry trainee, nearly a Consultant psychiatrist, currently funded by The Charity to study non-drug treatments for fatigue in people living with a brain tumour

Researchers at Glasgow University have discovered that ovarian cancer drug, olaparib, has the potential to treat patients with glioblastomas

A gene therapy to treat recurrent high-grade gliomas is accelerated to Phase 3 clinical trials, after the success of Phase 1 clinical trials by the US Food and Drug Administration (FDA)

A team of researchers at UCLA have discovered a combination of drugs to prevent the growth of glioblastomas, as well as kill tumour cells in mice with glioblastomas

A research team at the University of Texas, led by Professor George Biros have been able to accurately characterise gliomas using a super computer

Professor Frank Winkler and his team at Heidelberg University in Germany have discovered a potential mechanism that could explain glioma recurrence

Researchers at The Institute of Cancer Research identify new subgroups for high-grade glial tumours occurring in children

Researchers at Stanford University discover that the absence of a particular protein halts the growth of high-grade gliomas

We have awarded the Dutch/British WINDOW Consortium a grant of £1.5 million (€1.75 million) for research into Glioblastoma